What are you searching for?

Sign in
Breaking News, Promotions & Moves

Codiak BioSciences Appoints EVP

Dr. Robert M. Brenner will also serve as head of Research and Development at the company

Codiak BioSciences announced the appointment of Robert M. Brenner, M.D. as executive vice president and head of Research and Development. Dr. Brenner will serve on the executive leadership team and report to Codiak’s president and chief executive officer, Douglas E. Williams, Ph.D.

“Dr. Brenner’s experiences and accomplishments span the spectrum from research to commercial operations, in companies at a variety of stages of growth,” said Dr. Williams. “He brings broad drug development skills in recombinant proteins, cell therapies and small molecules, which will help to grow the Codiak pipeline and platform while strengthening our foremost position in pioneering exosome therapeutics.”


Dr. Brenner joins Codiak from Orionis Biosciences, where he was executive vice president and chief medical officer.  Previously, Dr. Brenner served as president and chief executive officer of AlloCure, a clinical-stage regenerative medicine company.  

“Through groundbreaking scientific discovery and industrial development, Codiak is driving advancement of exosome biology for therapeutic applications,” said Dr. Brenner. “I am thrilled to join the team at this exciting time, and I am eager to contribute to the future achievement of the company as we work to create a new pharmaceutical modality for the benefit of patients.”  
 
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics